Springbok's FSHD AI Model, 10X Genomics' $25M Lung Cancer Push, & BostonGene's Tech Leadership Win - Life AI Weekly #26

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in Healthcare & Life Sciences AI. This week, we have a range of exciting developments to share. Springbok Analytics has released a new AI model aimed at tracking the progression of Facioscapulohumeral Muscular Dystrophy (FSHD), while 10X Genomics and A*STAR have embarked on a $25 million research initiative focused on lung cancer. Additionally, Elix, Inc. has partnered with Eisai to enhance drug discovery using AI technologies.

In other news, TileDB and Databricks have joined forces to integrate AI into healthcare solutions, and Answer ALS has launched a collaborative effort to advance AI-driven drug development. Meanwhile, BostonGene has been recognized with the 2025 Technology Leadership Award for its contributions to the field. Stay tuned as we explore these stories and more in this edition.

The Tianqiao and Chrissy Chen Institute and AAAS have announced the winners of the inaugural AI Prize for AI Accelerated Research, highlighting achievements in molecular biology, neuroscience, and oceanic climate dynamics.

HOPPR launched the Marie Curie Chest Radiography Model, enhancing diagnostic capabilities in healthcare technology. This model aims to improve the accuracy and efficiency of chest radiography analysis.

HOPPR launches the Marie Curie Chest Radiography Model to enhance diagnostic accuracy in radiology. USOP partners with Adonis for AI-driven revenue management solutions. DNAKE enhances BCI technology with new solutions and partnerships.

HOPPR has introduced the Marie Curie Chest Radiography Model, enabling partners to fine-tune and deploy classifiers for chest X-ray images with API access and structured outputs. DeepHealth is the first to use this model commercially. U.S. Orthopaedic Partners has teamed up with Adonis to leverage AI technology for better efficiency and revenue collection. The partnership focuses on reducing denials and boosting operational capabilities as USOP expands in the Southeastern U.S DNAKE is advancing Brain-Computer Interface technology through innovative solutions and strategic collaborations with research institutions, focusing on improving human-machine interaction and addressing neurological disorders.